Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Taiwain Researchers Report New Marker For Liver Cancer Risk

This article was originally published in PharmAsia News

Executive Summary

Taiwan scientists report discovery of a new biomarker for liver cancer, one related to the hepatitis B virus. The researchers said identifying the indicator could aid in new diagnostic procedures. The research, to be published in the next issue of the Journal of the National Cancer Institute, suggests a patient with genotype C has as much as double the risk of developing cancer as one with genotype B of the hepatitis B virus. Further, if the virus has mutated, the risk changes up or down according to where the mutation occurs. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts